Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue

Last updated: February 14, 2025
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

Baduanjin exercise training (BET)

Clinical Study ID

NCT06829940
P.T.REC/012/005517
  • Ages 18-50
  • All Genders

Study Summary

Post-COVID recovery is associated with reduced functional fitness/capacity, low quality of life, and physical disabilities in those who survived after contracting the disease. The unpleasant symptoms of chronic post-viral/post-COVID syndrome (chronic fatigue perception, variant nonspecific myalgia, bad mood or depression, and insomnia or sleep disturbances) usually magnify the symptoms of already existing previously diagnosed concurrent untreatable chronic disorders , including the idiopathic chronic fatigue (ICF).(Leszczak et al., 2024)

Baduanjin exercise training (BET) is one of the Chinese traditional Health-Qigong exercises that not only integrate slow coordinating postures/positions, breathing techniques, musculoskeletal stretching movements/positions, and meditative mind but also plays a strong role concerning health benefits (e.g. musculoskeletal pain-reducing, sleep disturbance-enhancing effects, and fatigue-reducing effects) (Zou et al., 2018).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • • 40 patients will be recruited in the study.

  • age ≥ 18 to ≤ 50 years old

  • achieved three diagnostic items/criteria of ICF will be included in this BETtrial: Fatigue lasting over 6 months, which significantly limits dailyactivities, reducing the person's usual activity level by more than 50%, asconfirmed by a doctor.

At least three of the following symptoms:

Generalized muscle weakness Difficulty sleeping Frequent headaches A painful throat Muscle tenderness throughout the body Migratory joint pain Swollen lymph nodes in the neck or armpits Fatigue lasting more than a day after typical activities

Exclusion

Exclusion Criteria:

  • Patients with a history of medical or complementary treatments for ICF disorder inthe 6 months before contracting COVID or after recovery.

  • Individuals who have engaged in therapeutic exercise, pharmacological treatments, orcomplementary therapies for post-COVID symptoms within the last six months prior toenrollment.

  • ICF patients regularly using antidepressants or antipsychotics were excluded.

  • Those who take sleeping pills regularly were also excluded.

  • Patients with autoimmune diseases, malignant conditions, anemia, endocrinedisorders, systemic diseases, or osteoarthritis affecting the cervical spine, lumbarregion, or limbs were excluded.

  • Individuals with abnormal results in laboratory tests, including neurological,neurophysiological, cardiological, liver/kidney function tests, or urine/stoolanalyses (as determined by a physician) were excluded.

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Baduanjin exercise training (BET)
Phase:
Study Start date:
October 09, 2024
Estimated Completion Date:
March 01, 2025

Study Description

forty idiopathic chronic fatigue (ICF) patients will be randomly assigned into two equal groups (n=20)

  1. Study group (20 patients) this group will be supervised daily, except Fridays, during the 60-minute session of 12-week BET) or waitlist group

  2. Control group (20 patients)

Connect with a study center

  • Cairo University

    Cairo, 11432
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.